{"id":"https://openalex.org/W1969933742","doi":"https://doi.org/10.1038/jcbfm.2015.17","title":"Glucagon-Like Receptor 1 Agonists and DPP-4 Inhibitors: Potential Therapies for the Treatment of Stroke","display_name":"Glucagon-Like Receptor 1 Agonists and DPP-4 Inhibitors: Potential Therapies for the Treatment of Stroke","alternate_titles":[],"publication_year":2015,"publication_date":"2015-02-11","ids":{"openalex":"https://openalex.org/W1969933742","doi":"https://doi.org/10.1038/jcbfm.2015.17","mag":"1969933742","pmid":"https://pubmed.ncbi.nlm.nih.gov/25669907","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4420864"},"language":"en","primary_location":{"id":"doi:10.1038/jcbfm.2015.17","doi":"https://doi.org/10.1038/jcbfm.2015.17","is_oa":false,"landing_page_url":"https://doi.org/10.1038/jcbfm.2015.17","pdf_url":null,"source":{"id":"https://openalex.org/S89339265","display_name":"Journal of Cerebral Blood Flow & Metabolism","issn_l":"0271-678X","issn":["0271-678X","1559-7016"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cerebral Blood Flow &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1969933742"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4420864/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065472684","display_name":"Vladimer Darsalia","orcid":"https://orcid.org/0000-0002-6693-934X","observed_orcids":["https://orcid.org/0000-0002-6693-934X"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Vladimer Darsalia","raw_affiliation_strings":["Department of Clinical Science and Education, Karolinska Institutet, S\u00f6dersjukhuset, Internal Medicine, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Science and Education, Karolinska Institutet, S\u00f6dersjukhuset, Internal Medicine, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062811315","display_name":"Martin Larsson","orcid":"https://orcid.org/0000-0002-3226-7397","observed_orcids":["https://orcid.org/0000-0002-3226-7397"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Larsson","raw_affiliation_strings":["Department of Clinical Science and Education, Karolinska Institutet, S\u00f6dersjukhuset, Internal Medicine, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Science and Education, Karolinska Institutet, S\u00f6dersjukhuset, Internal Medicine, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109321925","display_name":"David Nathanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Nathanson","raw_affiliation_strings":["Department of Clinical Science and Education, Karolinska Institutet, S\u00f6dersjukhuset, Internal Medicine, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Science and Education, Karolinska Institutet, S\u00f6dersjukhuset, Internal Medicine, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032965517","display_name":"Thomas Klein","orcid":"https://orcid.org/0000-0001-5762-9166","observed_orcids":["https://orcid.org/0000-0001-5762-9166"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Klein","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041540706","display_name":"Thomas Nystr\u00f6m","orcid":"https://orcid.org/0000-0001-5489-2903","observed_orcids":["https://orcid.org/0000-0001-5489-2903"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Nystr\u00f6m","raw_affiliation_strings":["Department of Clinical Science and Education, Karolinska Institutet, S\u00f6dersjukhuset, Internal Medicine, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Science and Education, Karolinska Institutet, S\u00f6dersjukhuset, Internal Medicine, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090188680","display_name":"Cesare Patrone","orcid":"https://orcid.org/0000-0003-0470-4606","observed_orcids":["https://orcid.org/0000-0003-0470-4606"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210094988","display_name":"Stockholm South General Hospital","ror":"https://ror.org/00ncfk576","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210094988"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cesare Patrone","raw_affiliation_strings":["Department of Clinical Science and Education, Karolinska Institutet, S\u00f6dersjukhuset, Internal Medicine, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Science and Education, Karolinska Institutet, S\u00f6dersjukhuset, Internal Medicine, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5065472684"],"corresponding_institution_ids":["https://openalex.org/I28166907","https://openalex.org/I4210094988"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.432,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.40032949,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"35","issue":"5","first_page":"718","last_page":"723"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.5404999852180481,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.5404999852180481,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.21879999339580536,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.17900000512599945,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.925000011920929},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.847000002861023},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glp-1-receptor","display_name":"GLP-1 receptor","score":0.8169999718666077},{"id":"https://openalex.org/keywords/ischemic-stroke-treatment","display_name":"ischemic stroke treatment","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.9498464465141296},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6927633285522461},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.6887549161911011},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6630012392997742},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4639560580253601},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4341813027858734},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3615849018096924},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25234127044677734},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.1759096384048462},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11545604467391968},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1038/jcbfm.2015.17","doi":"https://doi.org/10.1038/jcbfm.2015.17","is_oa":false,"landing_page_url":"https://doi.org/10.1038/jcbfm.2015.17","pdf_url":null,"source":{"id":"https://openalex.org/S89339265","display_name":"Journal of Cerebral Blood Flow & Metabolism","issn_l":"0271-678X","issn":["0271-678X","1559-7016"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cerebral Blood Flow &amp; Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4420864","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4420864/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Cereb Blood Flow Metab","raw_type":"Text"},{"id":"pmid:25669907","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25669907","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4420864","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4420864/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Cereb Blood Flow Metab","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1481597127","https://openalex.org/W1628878549","https://openalex.org/W2006568691","https://openalex.org/W2009256046","https://openalex.org/W2016997908","https://openalex.org/W2026184257","https://openalex.org/W2031848004","https://openalex.org/W2045846363","https://openalex.org/W2051951378","https://openalex.org/W2055499860","https://openalex.org/W2059493767","https://openalex.org/W2064130493","https://openalex.org/W2067495573","https://openalex.org/W2075957269","https://openalex.org/W2080785707","https://openalex.org/W2087458050","https://openalex.org/W2088190876","https://openalex.org/W2094706071","https://openalex.org/W2102585787","https://openalex.org/W2110333911","https://openalex.org/W2115932722","https://openalex.org/W2120031987","https://openalex.org/W2127854619","https://openalex.org/W2128243640","https://openalex.org/W2139277949","https://openalex.org/W2142400535","https://openalex.org/W2148456968","https://openalex.org/W2158572298","https://openalex.org/W2159205789","https://openalex.org/W2161483908"],"related_works":["https://openalex.org/W2020197027","https://openalex.org/W2748692931","https://openalex.org/W3087075091","https://openalex.org/W6960299460","https://openalex.org/W4220654929","https://openalex.org/W2791751350","https://openalex.org/W4250497995","https://openalex.org/W2966370698","https://openalex.org/W2908687677","https://openalex.org/W7112850646"],"abstract_inverted_index":{"During":[0],"the":[1,12,37,76],"past":[2],"decades,":[3],"candidate":[4],"drugs":[5],"that":[6,52],"have":[7,15],"shown":[8,54],"neuroprotective":[9,55],"efficacy":[10],"in":[11,17,57],"preclinical":[13],"setting":[14],"failed":[16],"clinical":[18,62],"stroke":[19,27,45],"trials.":[20],"As":[21],"a":[22,48,84],"result,":[23],"no":[24],"treatment":[25],"for":[26,43],"based":[28],"on":[29],"neuroprotection":[30],"is":[31,47],"available":[32],"today.":[33],"The":[34],"activation":[35],"of":[36],"glucagon-like":[38],"peptide":[39],"1":[40],"receptor":[41],"(GLP-1)":[42],"reducing":[44],"damage":[46],"relatively":[49],"novel":[50,85],"concept":[51],"has":[53],"effects":[56],"animal":[58],"models.":[59],"In":[60],"addition,":[61],"studies":[63],"are":[64],"currently":[65],"ongoing.":[66],"Herein,":[67],"we":[68],"review":[69],"this":[70],"emerging":[71],"research":[72],"field":[73],"and":[74],"discuss":[75],"next":[77],"milestones":[78],"to":[79,82],"be":[80],"achieved":[81],"develop":[83],"antistroke":[86],"therapy.":[87]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1969933742","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
